ChemicalBook > CAS DataBase List > Rozanolixizumab

Rozanolixizumab

Product Name
Rozanolixizumab
CAS No.
1584645-37-3
Chemical Name
Rozanolixizumab
Synonyms
UCB7665;UCB-7665;Rozanolixizumab;Rozanolixizumab (anti-FCGRT);Research Grade Rozanolixizumab;Research Grade Rozanolixizumab(DHF14602)
CBNumber
CB28080992
Formula Weight
0
MOL File
Mol file
More
Less

Rozanolixizumab Property

storage temp. 
Store at -20°C
form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Rozanolixizumab Chemical Properties,Usage,Production

Uses

Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases[1].

in vivo

Intravenous (IV) rozanolixizumab dosing in cynomolgus monkeys demonstrated non-linear pharmacokinetics indicative of target-mediated drug disposition; single IV rozanolixizumab doses (30 mg/kg) in cynomolgus monkeys reduced plasma IgG concentration by 69% by Day 7 post-administration. Daily IV administration of rozanolixizumab (initial 30 mg/kg loading dose; 5 mg/kg daily thereafter) reduced plasma IgG concentrations in all cynomolgus monkeys, with low concentrations maintained throughout the treatment period (42 days)[1].

References

[1] Smith B, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs. 2018;10(7):1111-1130. DOI:10.1080/19420862.2018.1505464

Rozanolixizumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Rozanolixizumab Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58

1584645-37-3, RozanolixizumabRelated Search:


  • Rozanolixizumab
  • Research Grade Rozanolixizumab(DHF14602)
  • UCB7665
  • UCB-7665
  • Research Grade Rozanolixizumab
  • Rozanolixizumab (anti-FCGRT)
  • 1584645-37-3